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Introduction
Osteoarthritis (OA) is a leading cause of pain and functional impairment in working age adults and the elderly. However, patients who receive total joint replacement constitute only a minority of all OA patients. While the 20 th century prevalence and incidence of symptomatic or radiographic OA has been extensively studied, the impact of OA on health care use has been much less studied.
(1, 6, 8-10) Further, disease occurrence in OA is not in a steady state due to aging of the population and the major risk factor for OA which is increased body mass index. For instance, there is evidence that obesity increases the risk for knee OA, but an increase in risk of hip and hand OA has been reported as well. (11) (12) (13) (14) Thus, as the prevalence of obesity in most societies is projected to increase, it is expected that OA prevalence will increase as well. (15, 16) The prevalence of self-reported doctor diagnosed arthritis in US adults has been projected to increase from 22% in 2003 to 25% by 2030. (17) Presently there is a substantial lack of valid information on the future prevalence of OA leading to health care seeking. Expected changes in disease occurrence require changes in planning and resource prioritization. Hence, we posed two important questions: What proportions of the population consult due to OA at various joint sites? What proportions can be expected to consult a physician in the future?
Methods

Data sources
The Skåne region with 1.26 million inhabitants (by December 31, 2012) is located in southern Sweden, and contains both rural and urban areas. Primary and specialist level healthcare is provided by public and private payers through the same tax-based financing system. The patient's co-pay is similar irrespective of whether the care is provided by a public or private healthcare provider and it is common that patients seek care from, or are referred to, both types of providers.
A personal identification number is assigned to all Swedish residents and provides information on age and sex. Swedish law requires that all healthcare contacts are registered by the personal identification number, serving as the basis for reimbursement to the healthcare provider. The Skåne Healthcare Register (SHR) contains information about every healthcare contact made in the region and includes data on healthcare provider, the profession (physician, physical therapist etc.), type of contact (e.g. primary/specialist care, in-or outpatient visit, clinic etc.) and contact date. Furthermore, the register contains the publicly practicing physicians' diagnostic codes according to the International Classification of Diseases (ICD) 10 system. These codes are assigned by the doctors themselves and are retrieved from the electronic medical records to the register. The diagnostic codes assigned by privately practicing physicians are not forwarded to the register (while other details of the visit are).
The Swedish population register contains information about vital events such as births, deaths, and changes in residential address for all inhabitants in Sweden through the personal identification number. The register is continuously updated by the Swedish Tax Agency.
Statistics Sweden (SCB) provided us with individual information on income, which we linked by the personal identification number. SCB also provided age and sex specific longitudinal data on the prevalence of overweight and obesity and the population projection for Sweden until year 2032.
The study was approved by the Lund University Ethics Committee.
Multiple imputation of missing diagnoses
Of all persons who had at least one health care visit to a physician during the study period, 96% had at least one ICD-10 code registered. Of all physician health care visits 29.5% were made in the private care and had no diagnostic code registered, as the codes from private care
are not yet forwarded to the SHR (while other details of the visits are). We considered these codes to be missing at random and adjusted for this. 
Statistical analysis
We used a logit regression model to obtain the prevalence estimates with confidence intervals.
In a sensitivity analysis, we repeated the analyses using an expanded definition for OA, which incorporated a diagnosis of pain in joint (ICD-10 code: M25.5, no location specified) at age 55 years or older.(10) All presented prevalence numbers were based on the imputed data.
Analyses were performed using R (R Core Team) and STATA 13.
Results
Current point prevalence of doctor-diagnosed OA
The current proportion of the population aged ≥45 (n=531,254, 52% women) that had any (Figure 1 ). The prevalence typically increased with increasing age and was higher in women. (Table 3) .
Of all OA cases, 26.8% had been diagnosed with OA in more than one location. Knee OA and OA of other joints was the most common combination (10.9%). (Figure 1 ) Of all hand OA cases 53.6% had been diagnosed with OA in at least one other location.
When we expanded our OA definition to include a diagnostic code for 'joint pain' (location not specified) in those aged 55 years or older, the 2012 prevalence of OA in the population ≥45 was estimated to be 42.3% (36.4% in men and 47.7% in women).
Validation of knee OA diagnosis in the register (positive predictive values)
The probability of an ICD-10 code M17 diagnosis (knee OA) in the SHR to be in a MOA study subject fulfilling either the American Colleague of Rheumatology (ACR) clinical & radiographic criteria (with respect to the side) or having radiographic knee OA equivalent to Kellgren/Lawrence grade ≥2 was 88%.
Projected prevalence of OA to 2032
Taking into account only the projected changes in the sex-age structure of the population the prevalence of 'any OA', knee OA and hip OA, respectively, is expected to increase from 26.6% to 29.0%, from 13.8% to 15.2% and from 5.8% to 6.8%, respectively over the next two decades. When accounting additionally for the increase in the estimated prevalence of overweight and obesity the prevalence of 'any' OA, knee and hip OA may increase from 26.6% to 29.5%, from 13.8% to 15.7% for the knee and 5.8% to 6.9% for the hip, respectively. The pattern was similar for men and women ( Figure 2 ) This corresponds to the relative increase of 10%, 12% and 18%, respectively. Thus, by 2032 there may be over 26 000 more doctor diagnosed OA prevalent cases per 1 000 000 population aged 45 or older as compared to 2012. The grey areas in the Figure 2 show the impact of different assumptions on the increase in prevalence of overweight and obesity and its impact on the risk of OA as specified in the sensitivity analyses.
Discussion
We examined the current impact of OA on the health care system by determining the proportion of the population with doctor diagnosed OA using 14 years of comprehensive Swedish health register data. Currently, one in four adults aged ≥45 has doctor-diagnosed OA in at least one joint, excluding the spine, and more than one in eight had doctor-diagnosed OA of the knee. We also made projections over the next two decades. These projections indicate that almost 30% of adults aged ≥45 in 2032 are expected to have consulted for OA by 2032
and half of those for knee OA.
In our report the prevalence of OA in any location excluding spine in adults aged ≥45 that had We projected a relative increase on 10% over two decades (by year 2032) in the occurrence of 'any OA' that leads to health care consultation taking into account the future age and sex structure of the population as well as the prevalence of overweight and obesity. This increase is higher that the projected increase of self-reported doctor diagnosed arthritis from 29.6% in 2010 to 31.7% of the US population aged ≥20 when only change in age structure was Canada with a higher share of older adults. This shift didn't affect our results to the same extent as we used the age group 45 or older, a group typically affected by OA. Comparisons with other countries are challenging also due to different current and projected age and sex structures. Furthermore, our projection didn't take into account the potential for increased awareness of OA in the society which would increase the propensity to consult health care.
The current high prevalence of obesity and its expected increase in the populations over the world is another important factor that will affect the future prevalence of OA, especially of the knee.(35) Our results indicate though that the highest relative increase is to be expected in the hip OA. This is due to the greatest population growth in those aged 70 or older, where the hip OA is highly prevalent.
As a measure of impact on health care, we estimated the location-specific as well as the overall occurrence of doctor-diagnosed OA based on 14 years of data in a register with Importantly, our aim was not to estimate the occurrence of OA disease in general but only the occurrence of OA that directly impacts the health care system in terms of visits to a physician.
That is undoubtedly an underestimation of the "true" prevalence of the disease as about 40%
of symptomatic knee OA patients identified in the Malmö OA study hadn't consulted a physician due to knee OA or knee pain or didn't receive those diagnoses during the 3 years preceding the study examination (unpublished data). Primary care physicians may have difficulties with clinical examination of musculoskeletal disorders that could bias our estimates.(39) However, specialist care is relatively easily accessed in Sweden (even without referral from a primary care physician) and we used data over a 14-year period. In the Skåne region the formal guidelines for the diagnosis of OA were implemented first in 2012. The diagnoses registered between 1999 and 2011 were based on the physicians' clinical judgment.
However, the validity of rheumatic diagnoses in the SHR has been shown to be high. (40, 41) In the present study, we performed an extensive validation for knee OA against a number of OA criteria. The positive predictive value of knee OA diagnosis in SHR was 88% and is higher than for example in the Massachusetts health maintenance organization for OA in any location. (42) Our projections took into account the future age and sex structure of the population and the future prevalence of overweight and obesity. There are other factors, such as the incidence of knee injuries or willingness to consult that will impact the future prevalence of doctordiagnosed OA. The uncertainty of the population projections, the assumed increase in the prevalence of overweight and obesity and risk for developing OA at different joints sites all contribute to the uncertainty of the projection. We assumed that the linear increase in the prevalence of overweight and obesity observed between 1988 and 2010 would continue in the next 20 years, which might not hold true, e.g., if effective prevention programs will be implemented. We assumed the same mortality in persons with and without OA which could bias our estimates upwards if patients with OA will experience significantly higher mortality than the general population. The 2012 net immigration in the Skåne region was 0.07% of the population aged 45 or older and thus we expect that migration would have a negligible effect of the projected estimates when accounting for an increase in BMI. As we have studied the population aged 45 or older, we were not able to assess the potential increase in prevalence in younger patients.
Our results show that in 2012 almost one in seven adults aged ≥45 in Southern Sweden had doctor-diagnosed OA of the knee. As the 2012 prevalence of persons with knee prosthesis aged ≥45 in Sweden was 2.3%, it implies that 17% of prevalent doctor-diagnosed knee OA cases have undergone knee replacement surgery (unpublished data). By 2032, over 26 000 new OA cases per 1 000 000 population aged 45 or older will have consulted healthcare. To a large extent it will be the primary care physicians who will face the increased workload but a considerable stress on the health care system. In most western European countries the age of retirement is increasing and therefore, the future work force will include an increasing number of individuals suffering from OA. Prioritization of research on population health strategies to reduce OA, including weight loss and knee injury prevention, and, for those affected by OA, the development of effective therapies is needed. Further research on the burden of OA on health care is needed to evaluate the accuracy of these projections, especially since many previous predictions of both the incidence of surgery in OA and the prevalence of arthritis University, and Region Skåne. The funding sources had no influence on the study design, collection, analysis and interpretation of data, in the writing the manuscript or in the decision to submit the manuscript for publication.
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Where P is the number of persons with a disease, N is the number of persons in population, I
is the incidence rate of the disease and D is the disease duration.(4)
Equation 2:
The formula for the incidence rate in a population with a particular prevalence of overweight and obesity: = * + * * + * * * Where is the incidence rate in population, is the prevalence of normal weight (here defined as body mass index (BMI)≤25), is the prevalence of overweight (here defined as BMI between 25 and 30), is the prevalence of obesity (here defined as BMI>30); is the incidence rate in normal weight, is the relative increase in incidence rate due to the 5 unit increase in the BMI. We assume that this increase represents on average the transition from normal weight to overweight or from overweight to obesity (see Table 2 in this appendix to see values of that were used in the study).
Estimation of the incidence of Osteoarthritis.
The 2012 observed incidence of osteoarthritis (OA) was calculated using multiply imputed SHR data for all residents in Skåne any time between 1999 and 2012 (using the same model as described in the Supplementary Appendix B). All those having received a diagnosis of OA during the year 2012 and not having received a diagnosis of OA during 1999-2011 were considered to be incident cases of OA. The Skåne population at the Dec 31 st 2011 was used as denominator for incidence calculation. The 2012 prevalence estimates derived using the formula in equation 1 and the 2012 prevalence estimated directly from the data were consistent for knee, hip, hand and any OA.
